Meridian Bioscience, Inc. (NASDAQ:VIVO)

CAPS Rating: 5 out of 5

A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.

Recs

0
Player Avatar WilliamCrook2007 (< 20) Submitted: 11/20/2008 2:47:04 PM : Outperform Start Price: $20.40 VIVO Score: -77.54

ibd

Featured Broker Partners


Advertisement